SIGA vs. FLXN, ORGO, EBS, ETNB, GERN, VERA, AMPH, AGIO, AMRX, and RCKT
Should you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Flexion Therapeutics (FLXN), Organogenesis (ORGO), Emergent BioSolutions (EBS), 89bio (ETNB), Geron (GERN), Vera Therapeutics (VERA), Amphastar Pharmaceuticals (AMPH), Agios Pharmaceuticals (AGIO), Amneal Pharmaceuticals (AMRX), and Rocket Pharmaceuticals (RCKT). These companies are all part of the "medical" sector.
SIGA Technologies (NASDAQ:SIGA) and Flexion Therapeutics (NASDAQ:FLXN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.
In the previous week, SIGA Technologies had 9 more articles in the media than Flexion Therapeutics. MarketBeat recorded 9 mentions for SIGA Technologies and 0 mentions for Flexion Therapeutics. SIGA Technologies' average media sentiment score of 0.81 beat Flexion Therapeutics' score of 0.00 indicating that SIGA Technologies is being referred to more favorably in the media.
55.4% of SIGA Technologies shares are held by institutional investors. Comparatively, 90.0% of Flexion Therapeutics shares are held by institutional investors. 1.5% of SIGA Technologies shares are held by insiders. Comparatively, 9.1% of Flexion Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Flexion Therapeutics received 567 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 64.93% of users gave Flexion Therapeutics an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote.
SIGA Technologies has higher revenue and earnings than Flexion Therapeutics. Flexion Therapeutics is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks.
SIGA Technologies has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, Flexion Therapeutics has a beta of 1.53, indicating that its share price is 53% more volatile than the S&P 500.
SIGA Technologies has a net margin of 50.48% compared to Flexion Therapeutics' net margin of -100.32%. SIGA Technologies' return on equity of 51.97% beat Flexion Therapeutics' return on equity.
Summary
SIGA Technologies beats Flexion Therapeutics on 9 of the 15 factors compared between the two stocks.
Get SIGA Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SIGA Technologies Competitors List
Related Companies and Tools
